# OXCARBAZEPINE
> **ANDA206576** · Abbreviated New Drug Application (Generic) · Sponsor: TWI PHARMS INC · Approved 2018-11-29
## Drug
- **FDA Application Number:** ANDA206576
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXCARBAZEPINE
- **Generic name:** Oxcarbazepine
- **Active ingredients:** OXCARBAZEPINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TWI PHARMS INC
- **First approval:** 2018-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206576)
---
*MORVS · CC0 1.0*